医疗失效模式与效应分析在提高宫缩抑制剂使用安全性中的应用  

Application of healthcare failure mode and effect analysis in improving the safety of tocolytic agent usage

作　　者：余勇妙[1] 潘小兰[1] 钟瑞卿[1] 

机构地区：[1]肇庆市第一人民医院,广东肇庆526021

出　　处：《齐鲁护理杂志（中旬刊）》2012年第3期12-14,共3页Journal of Qilu Nursing

摘　　要：目的:探讨医疗失效模式与效应分析(HFMEA)方法在提高静脉滴注宫缩抑制剂安全性中的应用。方法:将2010年1月～2011年2月实施HFMEA静脉滴注宫缩抑制剂的219例患者作为观察组,对静脉滴注宫缩抑制剂的用药流程进行分析,针对不安全的因素调整制度、流程,使静脉滴注宫缩抑制剂的安全用药系统不断完善并得以持续改进;将2009年1～12月静脉滴注宫缩抑制剂的184例患者作为对照组。比较两组每个失效模式的风险指数(RPN)及按医嘱规定浓度和时间完成宫缩抑制剂输注率。结果:观察组按医嘱规定浓度和时间完成率明显高于对照组(P<0.01),每个失效模式的RPN值明显低于对照组(P<0.05)。结论:应用医疗失效模式与效应分析理论前瞻性地对在我科住院静脉滴注宫缩抑制剂的安全用药系统进行全过程分析,结合实际情况制定改善计划并落实,是确保宫缩抑制剂安全使用的保证。Objective：To investigate the application of healthcare failure mode （ HFMEA ） and effect analysis method in improving the safety of intravenous infusion of tocolytic agents. Methods ：219 patients who were treated with intravenous infusion of tocolytic agents in accordance with HFMEA from January 2010 to February 2011 were taken as the observation group. The procedure of intravenous infusion of tocolytic agent was analyzed and the adjustment of regulation and rules and the process was implemented to continuously improve and make medication system better against the unsafe factors in the intravenous infusion of tocolytic agent ;other 184 patients who received the treatment of intravenous infusion of tocolytic agents from January to December 2009 were taken as the control group. The healthcare failure mode, risk priority number （ RPN ） and the infusion completion rate of tocolytic agent abiding by doctor＇s prescription as the concentration of drugs and time of infusion were compared between the two groups. Results ：The infusion completion rate according to the concentration of drugs and time of infusion was significantly higher in the observation group than the control group （ P 〈 O. 01 ） ; the RPN value of each failure mode was significantly lower in the observation group than the control group （ P 〈 0.05 ）. Conclusion ： The healthcare failure mode and effect analysis theory applied to the analysis of the safety of whole process of medication system in our hospital can ensure the safety of intravenous infusion of tocolytic agent.

关 键 词：医疗失效模式与效应分析 宫缩抑制剂 安全性 

分 类 号：R192[医药卫生—卫生事业管理]